| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $81K | -92.1% |
| R&D Expense | $38.7M | +67.1% |
| SG&A Expense | $13.3M | +11.1% |
| Operating Income | -$51.9M | -52.2% |
| Net Income | -$48.8M | -47.9% |
| EPS (Basic) | -$1.83 | -33.6% |
| EPS (Diluted) | -$1.83 | -33.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $76.7M | -29.6% |
| Current Assets | $78.3M | -29.5% |
| Total Assets | $81.4M | -28.7% |
| Current Liabilities | $8.5M | -20.1% |
| Total Liabilities | $45.1M | -5.5% |
| Stockholders' Equity | $36.4M | -45.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$47.3M | -647.6% |
| Capital Expenditures | $153K | -58.2% |
| Investing Cash Flow | -$153K | +58.2% |
| Financing Cash Flow | $14.9M | -35.7% |
| Free Cash Flow | -$47.5M | -673.7% |